Conference Description
The Immunoengineering GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Immunoengineering is a vibrant, emerging field that improves human health by enabling the analysis, manipulation, and engineering of the immune system. Appropriate immune responses are essential to stave off and fight infection, and prevent the onset and progression of diseases such as cancer, heart disease, neurodegeneration and allergy/autoimmunity. Grounded in fundamental immunology discoveries, the integration of principles from engineering and the physical sciences into immunological research has accelerated in the last decade. Representative landmark Immunoengineering breakthroughs include engineered immune cells as therapeutics (CAR T cells) and bi-specific antibodies that are now used in the clinic and have been approved for the treatment of cancer, as well as novel vaccines that address SARS-CoV-2, Ebola, and other urgent global health concerns. And progress continues as nucleic acid technologies that started as mRNA vaccines are now moving toward cancer therapy applications.
Following on the success of the inaugural meeting in 2022, the 2024 Gordon Research Conference will bring together the broader Immunoengineering community for the interactive exchange of ideas between immunologists, clinicians, engineers, chemists, physicists, mathematicians, and systems biologists. The goal of the meeting is to facilitate fundamental and translational science, catalyze new ideas, and spark collaborations by providing a scientific “home” for this interdisciplinary community. Sessions will highlight contemporary molecular, cellular, and tissue-scale Immunoengineering advances and translational successes and insights borne from the broader landscape of Immunoengineering.
We invite attendees to apply to attend this event, and join in making the 2024 Immunoengineering GRC another landmark event in the development of this field. Attendees will be joining an interdisciplinary group of researchers at all career stages and many nationalities. All attendees are encouraged to bring an open mind and their ideas to spark new collaborations, and help shape the development of this community and field.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by October 14, 2023. Please check back for updates.
Keynote Session: Pioneers of Immunoengineering
Discussion Leaders
-
Marco Colonna (Washington University School of Medicine, United States)
-
Yvonne Chen (University of California, Los Angeles, United States)
Speakers
-
Jeffrey Hubbell (University of Chicago, United States)
-
Stanley Riddell (Fred Hutchinson Cancer Center, United States)
Engineering the Aging Immune System
Discussion Leaders
-
Erika Moore (University of Maryland, College Park, United States)
Speakers
-
Janko Nikolich (University of Arizona, United States)
-
Evan Scott (Northwestern University, United States)
-
Maxim Artyomov (Washington University, St. Louis, United States)
Regenerative Immunoengineering
Discussion Leaders
-
Priscilla Briquez (Medical Center - University of Freiburg, Germany)
Speakers
-
Andres Garcia (Georgia Institute of Technology, United States)
-
Kara Spiller (Drexel University, United States)
Tissue Immunity and Models
Discussion Leaders
-
Kara Spiller (Drexel University, United States)
Speakers
-
Rebecca Pompano (University of Virginia, United States)
-
David Beebe (UW-Madison, United States)
-
Britta Engelhardt (University of Bern, Switzerland)
Neuroimmunology and Immunometabolism
Discussion Leaders
-
Kavita Dhodapkar (Emory, United States)
Speakers
-
David Hafler (Yale School of Medicine, United States)
-
Greg Delgoffe (University of Pittsburgh, United States)
Immunoengineered Cell Therapies For Cancer
Discussion Leaders
-
Pedro Romero (Novigenix SA, Switzerland)
Speakers
-
George Coukos (Lausanne University Hospital CHUV/UNIL, Ludwig Cancer research Lausanne branch, Switzerland)
-
Avery Posey, Jr. (University of Pennsylvania, United States)
-
Sai Reddy (ETH Zurich, Switzerland)
Pathogen Systems Immunology and Sensing
Discussion Leaders
-
Victor Greiff (University of Oslo, Norway)
Speakers
-
Bali Pulendran (Stanford University, United States)
-
Jose L Garcia Cordero (Roche Institute of Human Biology, Switzerland)
Immunoengineering Pathogens
Discussion Leaders
-
Katharina Maisel (University of Maryland, United States)
Speakers
-
Bana Jabri (University of Chicago, United States)
-
Noah Palm (Yale School of Medicine, United States)
Molecular and Systems Immunoengineering in Cancer
Discussion Leaders
-
Jamal Lewis (University of Florida, United States)
Speakers
-
Stacey Finley (University of Southern California, United States)
-
Jamie Spangler (Johns Hopkins University, United States)
The GRC Power Hour™
Organizers
-
Katharina Maisel (University of Maryland, United States)
-
Priscilla Briquez (Medical Center - University of Freiburg, Germany)